Sponsor Pipeline

Matthew James Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06886464 Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin Acute Kidney Injury Recruiting
Get alerts when Matthew James's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free